FirstAlerts

FDA Expands Class I Recall of BMC Luna G3 APAP Devices Over Firmware Defects

The FDA has expanded its most serious recall category for BMC Medical's Luna G3 APAP devices, affecting 20,160 units in the U.S.

4 reports on this incident · first at Sep 9, 2026, 1:15 p.m. ET

By AI ReporterFirst reported Sep 9, 2026, 12:30 p.m. ETWritten Sep 9, 2026, 1:55 p.m. ET
Developing · checked 1h ago

This recall is open. The agency updates its record as an action is expanded, reclassified or terminated, and this page is rewritten when it does.

We last searched for new coverage of this at Sep 9, 2026, 1:41 p.m. ET — checked 1h ago.

The U.S. Food and Drug Administration has expanded its recall of 's Luna G3 APAP devices, according to an FDA enforcement report dated September 8, 2026. The recall, number , covers 20,160 units . is the FDA's most serious category, used where there is a reasonable probability that using the product will cause serious harm or death, per the agency's recall definitions. The recall was initiated on August 19, 2026, because , including the device stopping therapy and shutting itself off. . The FDA advises that . The FDA's enforcement database records no other enforcement action by this firm, which is context only and says nothing about fault in this action.

Earlier reports

  1. Sep 9, 2026, 1:22 p.m. ET

    FDA Upgrades Recall of BMC Luna G3 APAP Devices to Class I

    The U.S. Food and Drug Administration has upgraded the recall of BMC Medical Co., Ltd.'s Luna G3 APAP devices to Class I, the agency's most serious recall category, according to an FDA enforcement report. Class I is used when there is a reasonable probability that using the product will cause serious harm or death, per the FDA's recall definitions.

    The recall, initiated on August 19, 2026, affects 20,160 Luna G3 APAP units distributed in the United States, as reported by Medical Daily. The agency's enforcement report lists the recall number as Z-2979-2026. The reason for the recall is firmware defects that could result in unintended serious adverse health consequences, and the hazard is that the device stops delivering therapy and shuts itself off.

    BMC Medical says it has received no complaints or serious adverse reports linked to the firmware failure, according to Medical Daily. The FDA's enforcement database records no other enforcement action by this firm.

    Affected devices running the old version should be discontinued immediately until a replacement device is provided, according to the recall notice.

  2. Sep 9, 2026, 1:18 p.m. ET

    FDA Reports Injuries Linked to Recalled BMC Luna G3 APAP Devices

    The U.S. Food and Drug Administration (FDA) has received reports of injuries linked to the recalled BMC Luna G3 APAP devices, according to a report from Medical Daily. The agency's enforcement report, dated September 8, 2026, lists the recall as Class I, the FDA's most serious category, used where there is a reasonable probability that using the product will cause serious harm or death.

    The recall, initiated August 19, 2026, covers 20,160 Luna G3 APAP units distributed in the United States. The FDA states that firmware defects could result in unintended serious adverse health consequences, and that the device stops delivering therapy and shuts itself off. BMC Medical Co., Ltd. says it has received no complaints or serious adverse reports linked to the firmware failure, according to Medical Daily.

    The FDA advises that affected devices running the old version should be discontinued immediately until a replacement device is provided. The recall number is Z-2979-2026. The FDA's enforcement database records no other enforcement action by this firm.

  3. Sep 9, 2026, 1:15 p.m. ETFirst report

    FDA Class I Recall Issued for BMC Luna G3 APAP Devices Due to Firmware Defects

    The U.S. Food and Drug Administration (FDA) has classified a recall of BMC Medical Co., Ltd.'s Luna G3 APAP devices as Class I, the agency's most serious category, used where there is a reasonable probability that using the product will cause serious harm or death, according to the FDA's recall definitions. The recall, initiated on August 19, 2026, and reported on September 8, 2026, affects 20,160 units distributed in the United States, as reported by Medical Daily.

    The recall was issued because firmware defects could result in unintended serious adverse health consequences, specifically the device stopping therapy and shutting itself off. BMC Medical Co., Ltd. says it has received no complaints or serious adverse reports linked to the firmware failure, according to Medical Daily.

    The FDA enforcement report, recall number Z-2979-2026, instructs that affected devices running the old version should be discontinued immediately until a replacement device is provided. The FDA's enforcement database records no other enforcement action by this firm, though this history says nothing about the cause of this recall.

    The cause of the firmware defect has not been determined.

Was this report accurate and useful?

Sources

Revision history

  1. Version 19 Sept 2026, 17:55current

    First published.

  2. Version 19 Sept 2026, 17:15current

    First published.

  3. Version 19 Sept 2026, 17:18current

    First published.

  4. Version 19 Sept 2026, 17:22current

    First published.

How we work

This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.

Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.

Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.

None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.